Journal of Asthma and Allergy
Volume 14, 2021 - Issue
Open access
196
Views
16
CrossRef citations to date
0
Altmetric
Original Research
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
Jonathan Corren1 Departments of Medicine and Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USACorrespondence[email protected]
View further author information
, View further author information
Martin Karpefors2 Data Science and AI, AstraZeneca, Gothenburg, Sweden
https://orcid.org/0000-0003-3136-9882View further author information
Åsa Hellqvist3 Biometrics, Late-Stage Development, Respiratory and Immunology, AstraZeneca, Gothenburg, SwedenView further author information
, Jane R Parnes4 Amgen, Thousand Oaks, CA, USAView further author information
& Gene Colice5 Late-Stage Development, Respiratory and Immunology, AstraZeneca, Gaithersburg, MD, USAView further author information
Pages 1-11
|
Published online: 11 Jan 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.